Journals / Turkish Journal of Family Medicine and Primary Care / 2016 / Cilt: 10 - Sayı: 2

İlaç Kullanım Uyumuna Engeller

Barriers to Drug Adherence

Pages
58–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Inadherence warrants a bio-psychosocial approach and seemingly inadherent patients must be provided with a higher level of communication Key-Words: Inadherence, bio-psychosocial approach, indirect adherence measurement, barriers to adherence

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This manuscript aims to investigate the patient"s side of the problem through indirect method of adherence measurement via patient questionnarie.
📊
Key Findings & Data:Methods: 792 patients of family practice outpatient clinic ( 400 female and 392 male )were recruited and given a questionnarie as to list their reasons for drug inadherence Results: Reasons for inadherence were as follows; Unwillingness to use drugs (42,04%), Media effects (38,76%), Forgetfullness (34,59%), Poor communication with health care provider (33,58%), Drug side effects (24,11%), Refusing the disease (22,22%), Multiple drug use already (19,06%), Concerns for accuracy of treatment (10,6%), and High costs of drugs (6,1%) Conclusion: Patients are explicitly effected by many factors for adherence.
💡
Conclusion & Impact:Inadherence warrants a bio-psychosocial approach and seemingly inadherent patients must be provided with a higher level of communication Key-Words: Inadherence, bio-psychosocial approach, indirect adherence measurement, barriers to adherence
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This manuscript aims to investigate the patient"s side of the problem through indirect method of adherence measurement via patient questionnarie. Background: Lately, several phases to accomplish that patients continue therapy for chronic conditions for long periods has passed. Initially the patient was thought to be the core of the problem of compliance. The role of the health care providers was also addressed soon. Now we acknowledge that a system approach is required. The idea of compliance is associated too closely with blame, be it of providers or patients and the concept of adherence is a better way for understanding the dynamic changes required to maintain health over long periods of time. Methods: 792 patients of family practice outpatient clinic ( 400 female and 392 male )were recruited and given a questionnarie as to list their reasons for drug inadherence Results: Reasons for inadherence were as follows; Unwillingness to use drugs (42,04%), Media effects (38,76%), Forgetfullness (34,59%), Poor communication with health care provider (33,58%), Drug side effects (24,11%), Refusing the disease (22,22%), Multiple drug use already (19,06%), Concerns for accuracy of treatment (10,6%), and High costs of drugs (6,1%) Conclusion: Patients are explicitly effected by many factors for adherence. Improved adherence is primarily driven by improved management of diseases, including the increase awareness of issues surrounding adherence. That counts the physicians too. Inadherence warrants a bio-psychosocial approach and seemingly inadherent patients must be provided with a higher level of communication Key-Words: Inadherence, bio-psychosocial approach, indirect adherence measurement, barriers to adherence

Özet

Bu çalışmada hastaların ilaç kullanımına uyumlarını indirek bir ölçüm yöntemi olan hasta anketi ile sorunun hasta tarafı ele alınmaya çalışılmıştır Giriş: Son dönemlerde hastaların uzun süreli ilaç kullanımına uyum göstermeleri konusunda çeşitli safhalar geçilmiştir. Başlarda tek suçlunun hastanın kendisi olduğu düşünülse de hekimlerin bu konudaki rolleri de çabucak dikkat çekmiştir. Şimdi ise sistemik bir yaklaşımın gerekliliği kabul edilmektedir. Uyum; hastalar veya hekimler kaynaklı da olsa suçlandırılma ile ilişkilidir ve sağlığı korumak için ilaç kullanımına bağlılık olarak düşünülebilecek bir konsept, dinamik değişkenleri çözümleyebilmek açısından daha kullanışlı olacaktır. Metod: Aile hekimliği polikliniğine başvuran 792 hasta (400 kadın-392 erkek) çalışmaya kaydedilerek ilaç kullanım uyumsuzluklarının nedenleri açısından ankete tabi tutulmuşlardır. Bulgular: İlaç kullanımına uyumsuzluk nedenleri şöyle sıralandı; İlaç kullanımını istememek ( %42,04), Medya etkisi (%38,76), Unutmak (%34,59), Hekim ile kötü iletişim(%33,58), İlaçların yan etkileri (%24,11), Hastalığı reddetmek (%22,22), Çoklu ilaç kullanımı (%19,06), Tedavinin doğruluğuna güvensizlik(%10,6), ve son olarak yüksek ilaç fiyatları (%6,1) Sonuç: Hastalar açıkça pek çok faktörün etkisi altındadırlar. İlaç kullanımına uyum, temel olarak uyumla ilgili tüm konuların farkında olunması ve hastalıkların iyi yönetilmesi ile gelişir. Buna tabi ki hekimler de dahildir! İlaç kullanım uyumsuzluğu dikkatli bir biyo-psikososyal yaklaşım ve iyi bir iletişim gerektirir.

🔖

Cite This Article

ÖZŞAHİN, A. K., HAYDARDEDEOĞLU, F. E. (2016). İlaç Kullanım Uyumuna Engeller. Turkish Journal of Family Medicine and Primary Care, Cilt: 10 - Sayı: 2, 58–62. https://ajindex.com/articles/371371

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Yach D. Adherence to Long Term Therapies / Evidence for Action, WHO 2003. http://www.who.int/chp/knowledge/publications/a dherence_introduction.pdf Haynes RB, Taylor DW, Sackett DL. Compliance in University Press;1979. Hopkins Kurtz SMS: Adherence to diabetes regimens: empirical status and clinical applications. Diabetes Educ 1990;16:50 -56. Glasgow RE, McCaul KD, Schafer LC: Self-care behaviors and glycemic control in type 1 diabetes. J Chron Dis 1987;40:399 -412. Kravitz RL, Hays, RD, Sherbourne CD, DiMatteo MR, Rogers WH, Ordway L, Green-field S. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 1993;153:1869-1878.
  2. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331-6.
  3. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58:1126-32. 2010 benchmarks in improving medication adherence. Health Intelligence Network 2010. http://www.hin.com/library/PreviewMedicationAd herenceBenchmarks.pdf. erişim tarihi:04.01.2015 9. Osterberg L, Blaschke medication. N Engl J Med. 2005;353:487-489. Mentré F, Chenel M, Comets E, Grevel J, Hooker A, Karlsson MO et al. Current use and developments needed for optimal design in pharmacometrics: A study performed among DDMoRe's Pharmaceutical Members. CPT Pharmacometrics Syst Pharmacol 2013 Jun 5;2:e46. Federation and Industries Associations Rudd P. Helping patients follow the treatments you prescribed. In: Sack-ett DL, Haynes RB, Guyatt GH, Tugwell P, editors. Clinical 62